Physician profile
Caleb M Steffen
NPI 1275844771
$2,071.57
in general payments reported to CMS, 2019-2025
25 companies · $457 in 2025
The $457 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.75 · 2020: $530 · 2021: $209 · 2022: $311 · 2023: $54.43 · 2024: $415 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $926.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $520.34 | 2020-2025 | |
| Vertex Pharmaceuticals Incorporated | $174.78 | 2024-2025 | |
| Kerecis Limited | $141.75 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Merz North America, INC. | $139.80 | 2024-2025 | |
| Sientra, INC. | $121.01 | 2022 | |
| Allergan, INC. | $113.23 | 2019-2022 | |
| Organogenesis INC. | $107.33 | 2022-2025 | Puraply Wound Matrix, Simplimax |
| Abbvie INC. | $105.38 | 2024-2025 | |
| Axogen | $90.67 | 2020-2025 | |
| Stryker Corporation | $72.36 | 2021-2024 | Colorado, Na, Vsp System, Vsp Cranial |
| Tela Bio, INC. | $62.24 | 2021 | |
| Depuy Synthes Sales INC. | $57.18 | 2019-2022 | |
| Integra Lifesciences Corporation | $54.17 | 2021-2023 | Durasorb Monofilament Mesh |
| Revance Therapeutics, INC. | $45.06 | 2025 | Daxxify |
| Solventum Corporation | $39.34 | 2025 | Activ.A.C. |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifenet Health | $34.85 | 2024-2025 | Theragenesis Wound Matrix |
| Ethicon US, LLC | $34.37 | 2022 | |
| Baxter Healthcare | $31.74 | 2021 | |
| Paratek Pharmaceuticals, INC. | $22.05 | 2021 | |
| Davol INC. | $21.09 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $21.00 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $20.10 | 2024 | Libtayo |
| Kci USA, INC. | $15.26 | 2021 | |
| Coopersurgical, INC. | $13.40 | 2019 | |
| Zimmer Biomet Holdings, INC. | $13.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Steffen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.